Testing an ointment for actinic keratosis on the face
Part of Cancer, Skin clinical trials.
This trial tests an ointment called HW211026 for people with actinic keratosis, a common skin condition caused by sun damage. The study will check if the ointment is safe and works when applied to a 10 cm by 10 cm area on the face.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have actinic keratosis confirmed by a skin biopsy, with mild to moderate severity (grades 1 or 2).
- You have a 100 cm² area on your face (about 10 cm by 10 cm) that contains actinic keratosis lesions, but not on your lips, around your mouth, eyelids, eye area, nostrils, or inside your ears.
- You are willing to keep the treated area out of direct sunlight and UV light during the study.
- You have not used any ointments or creams for actinic keratosis on the treatment area in the last 3 months.
- You have not taken any pills or received injections for actinic keratosis in the last 6 months.
- You do not have other skin diseases like eczema or psoriasis in the treatment area, or severe heart or blood vessel problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how a new drug works in people with actinic keratosis (rough, scaly patches caused by sun damage) on their upper arms or face. You will receive the treatment and have blood samples taken to see how your body processes the medication.
This study tests a new sunscreen (Anthelos Fluide 100 KA+ UVMune 400) to see if it can protect skin and prevent further sun damage in people who already have multiple actinic keratoses (precancerous spots). It may help reduce the risk of new spots or skin cancer.
This study tests whether tirbanibulin (Klisyri) cream works well on specific types of actinic keratosis on the scalp or face that have a downward growth pattern. It helps doctors understand if this treatment is right for those skin spots.
This study tests a cream called tirbanibulin (Klisyri) for adults with 4 to 12 actinic keratosis (AK) spots on their face. It aims to see how well the treatment works when applied to a larger area of the face in everyday medical practice.
This trial tests an investigational gel called HW211026 for people with actinic keratosis, a common precancerous skin condition. It aims to see if the gel is a safe and effective treatment for lesions on the face.
This trial tests a new ointment called CU-10101. It will first be tested in healthy volunteers to check safety, and then in people with atopic dermatitis (eczema) to see how well it works for mild to moderate symptoms.
Hear when a new Actinic Keratosis (AK) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.